These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20829800)

  • 1. Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI ≥35 kg/m².
    Klein S; Ghosh A; Cremieux PY; Eapen S; McGavock TJ
    Obesity (Silver Spring); 2011 Mar; 19(3):581-7. PubMed ID: 20829800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses.
    McGlone ER; Carey I; Veličković V; Chana P; Mahawar K; Batterham RL; Hopkins J; Walton P; Kinsman R; Byrne J; Somers S; Kerrigan D; Menon V; Borg C; Ahmed A; Sgromo B; Cheruvu C; Bano G; Leonard C; Thom H; le Roux CW; Reddy M; Welbourn R; Small P; Khan OA
    PLoS Med; 2020 Dec; 17(12):e1003228. PubMed ID: 33285553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bariatric surgery is expensive but improves co-morbidity: 5-year assessment of patients with obesity and type 2 diabetes.
    Wu T; Wong SKH; Law BTT; Grieve E; Wu O; Tong DKH; Leung DKW; Ng EKW; Lam CLK; Wong CKH
    Br J Surg; 2021 May; 108(5):554-565. PubMed ID: 34043776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study.
    Keating C; Neovius M; Sjöholm K; Peltonen M; Narbro K; Eriksson JK; Sjöström L; Carlsson LM
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):855-65. PubMed ID: 26386667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.
    Kalsekar I; Iyer S; Mody R; Rajagopalan R; Kavookjian J
    J Manag Care Pharm; 2006 Mar; 12(2):121-9. PubMed ID: 16515370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of optimal perioperative glucose control on morbidly obese patients undergoing bariatric surgery.
    Zaman JA; Shah N; Leverson GE; Greenberg JA; Funk LM
    Surg Endosc; 2017 Mar; 31(3):1407-1413. PubMed ID: 27450209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exenatide, pen insulin, and vial insulin on patient outcomes: a retrospective database analysis of persistence and first-year costs in a commercially insured population.
    Rashid N; McCombs JS; Schwartz E
    Clin Ther; 2012 May; 34(5):1145-58. PubMed ID: 22464691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic review.
    Campbell JA; Venn A; Neil A; Hensher M; Sharman M; Palmer AJ
    Obes Rev; 2016 Sep; 17(9):850-94. PubMed ID: 27383557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the economic impact of bariatric surgery.
    Cremieux PY; Buchwald H; Shikora SA; Ghosh A; Yang HE; Buessing M
    Am J Manag Care; 2008 Sep; 14(9):589-96. PubMed ID: 18778174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of bariatric surgery on health care costs of obese persons: a 6-year follow-up of surgical and comparison cohorts using health plan data.
    Weiner JP; Goodwin SM; Chang HY; Bolen SD; Richards TM; Johns RA; Momin SR; Clark JM
    JAMA Surg; 2013 Jun; 148(6):555-62. PubMed ID: 23426865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes.
    Borah BJ; Darkow T; Bouchard J; Aagren M; Forma F; Alemayehu B
    Clin Ther; 2009 Mar; 31(3):623-31. PubMed ID: 19393853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the real-world effect of laparoscopic bariatric surgery on the management of obesity-related comorbidities: A retrospective matched cohort study using a US Claims Database.
    Patkar A; Fegelman E; R Kashyap S; Brethauer S; Bour E; Yoo A; Li G
    Diabetes Obes Metab; 2017 Feb; 19(2):181-188. PubMed ID: 27684382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Bariatric Surgery and National Medication Use.
    Morton JM; Ponce J; Malangone-Monaco E; Nguyen N
    J Am Coll Surg; 2019 Feb; 228(2):171-179. PubMed ID: 30453056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric Surgery for Adults With Class I Obesity and Difficult-to-Manage Type 2 Diabetes: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(8):1-151. PubMed ID: 38130940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study.
    Edelman SV; Ermakova A; Xiong Y; Sieradzan R; Taylor SD
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1420-1431. PubMed ID: 31550190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Bariatric Surgery on Cardiovascular Events and Metabolic Outcomes in Obese Patients with Insulin-Treated Type 2 Diabetes: a Retrospective Cohort Study.
    Alkharaiji M; Anyanwagu U; Donnelly R; Idris I
    Obes Surg; 2019 Oct; 29(10):3154-3164. PubMed ID: 31392579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and insulin use as identifiers of high-cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data.
    Johnston SS; Ammann EM; Kashyap SR; Stokes A; Hsiao CC; Daskiran M; Scamuffa R
    Diabetes Obes Metab; 2019 Jun; 21(6):1419-1428. PubMed ID: 30768824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of Bariatric Surgery: Increasing the Economic Viability of the Most Effective Treatment for Type II Diabetes Mellitus.
    Warren JA; Ewing JA; Hale AL; Blackhurst DW; Bour ES; Scott JD
    Am Surg; 2015 Aug; 81(8):807-11. PubMed ID: 26215244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
    Lemus R; Karni D; Hong D; Gmora S; Breau R; Anvari M
    Surg Endosc; 2018 Feb; 32(2):990-1001. PubMed ID: 28842774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.